{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:16:00Z","timestamp":1792804560656,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.radonc.2003.10.005","type":"journal-article","created":{"date-parts":[[2004,3,17]],"date-time":"2004-03-17T11:29:34Z","timestamp":1079522974000},"page":"261-264","source":"Crossref","is-referenced-by-count":184,"title":["Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients"],"prefix":"10.1016","volume":"70","author":[{"given":"Dirk","family":"Rades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Fehlauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Bajrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Mahlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckart","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2003.10.005_BIB1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/srao.2003.50006","article-title":"Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy","volume":"13","author":"Andreassen","year":"2003","journal-title":"Semin Radiat Oncol"},{"issue":"19","key":"10.1016\/j.radonc.2003.10.005_BIB2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/sonc.2002.37346","article-title":"Phase II trial of subcutaneous amifostine in patients undergoing radiation therapy for head and neck cancer","volume":"29","author":"Anne","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0360-3016(01)02683-9","article-title":"Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer","volume":"52","author":"Antonadou","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB4","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1046\/j.1365-2133.2000.03847.x","article-title":"Two cases of Stevens\u2013Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy","volume":"143","author":"Atahan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0360-3016(99)00532-5","article-title":"A randomized study of very accelerated radiotherapy with and without amifostine in advanced head and neck squamous cell carcinoma","volume":"46","author":"Bourhis","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0360-3016(01)02660-8","article-title":"The role of intensity-modulated radiotherapy in the treatment of parotid tumors","volume":"52","author":"Bragg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB7","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1008282412670","article-title":"Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer","volume":"9","author":"Buntzel","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/jjco\/hyf095","article-title":"Amifostine-induced toxic epidermal necrolysis during radiotherapy: a case report","volume":"32","author":"Demiral","year":"2002","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB11","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1200\/JCO.2000.18.11.2226","article-title":"Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study","volume":"18","author":"Koukourakis","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0167-8140(00)00235-8","article-title":"Has the outlook improved for amifostine as a clinical radioprotector?","volume":"57","author":"Lindegaard","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0360-3016(94)90562-2","article-title":"Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction","volume":"29","author":"McDonald","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-8140(86)80096-2","article-title":"Target cell and mode of radiation injury in rhesus salivary glands","volume":"7","author":"Stephens","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/1097-0142(19910315)67:6<1539::AID-CNCR2820670613>3.0.CO;2-Q","article-title":"Radiation apoptosis of serous acinar cells of salivary and lacrimal glands","volume":"67","author":"Stephens","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2003.10.005_BIB16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0360-3016(99)00559-3","article-title":"Common toxicity criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy","volume":"47","author":"Trotti","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2003.10.005_BIB17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0167-8140(02)00152-4","article-title":"The dose to the parotid glands with IMRT for oropharyngeal tumors: the effect of reduction of positioning margins","volume":"64","author":"Van Asselen","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2003.10.005_BIB18","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00001813-200203000-00015","article-title":"Life-threatening anaphylactoid reaction of amifostine used in concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review","volume":"13","author":"Vardy","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.radonc.2003.10.005_BIB19","first-page":"1519","article-title":"Active versus passive absorption kinetics as the basis for selective protection of normal tissues by S-2(3-aminopropylamino)-ethylphosphorothioic acid","volume":"40","author":"Yuhas","year":"1980","journal-title":"Cancer Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814003003852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814003003852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T16:00:44Z","timestamp":1550160044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814003003852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0167814003003852"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2003.10.005","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}